HUMA logo

Humacyte (HUMA) Company Overview

Profile

Full Name:

Humacyte, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

December 1, 2020

Indexes:

Not included

Description:

Humacyte is a biotechnology company that develops human tissue products for medical use. They create bioengineered blood vessels to help patients with vascular diseases. Their innovative approach aims to improve treatments and outcomes for those needing surgeries or transplants, making healthcare safer and more effective.

Events Calendar

Earnings

Next earnings date:

Mar 21, 2025

Recent quarterly earnings:

Nov 8, 2024

Recent annual earnings:

Mar 22, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 27, 25 D. Boral Capital
Buy
Feb 27, 25 Benchmark
Buy
Feb 26, 25 D. Boral Capital
Buy
Jan 21, 25 D. Boral Capital
Buy
Jan 13, 25 D. Boral Capital
Buy
Dec 23, 24 Benchmark
Buy
Dec 20, 24 HC Wainwright & Co.
Buy
Dec 20, 24 D. Boral Capital
Buy
Nov 21, 24 D. Boral Capital
Buy
Nov 18, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Humacyte?
  • Does Humacyte pay dividends?
  • What sector is Humacyte in?
  • What industry is Humacyte in?
  • What country is Humacyte based in?
  • When did Humacyte go public?
  • Is Humacyte in the S&P 500?
  • Is Humacyte in the NASDAQ 100?
  • Is Humacyte in the Dow Jones?
  • When was Humacyte's last earnings report?
  • When does Humacyte report earnings?
  • Should I buy Humacyte stock now?

What is the ticker symbol for Humacyte?

The ticker symbol for Humacyte is NASDAQ:HUMA

Does Humacyte pay dividends?

No, Humacyte does not pay dividends

What sector is Humacyte in?

Humacyte is in the Healthcare sector

What industry is Humacyte in?

Humacyte is in the Biotechnology industry

What country is Humacyte based in?

Humacyte is headquartered in United States

When did Humacyte go public?

Humacyte's initial public offering (IPO) was on December 1, 2020

Is Humacyte in the S&P 500?

No, Humacyte is not included in the S&P 500 index

Is Humacyte in the NASDAQ 100?

No, Humacyte is not included in the NASDAQ 100 index

Is Humacyte in the Dow Jones?

No, Humacyte is not included in the Dow Jones index

When was Humacyte's last earnings report?

Humacyte's most recent earnings report was on Nov 8, 2024

When does Humacyte report earnings?

The next expected earnings date for Humacyte is Mar 21, 2025

Should I buy Humacyte stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions